Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study
ConclusionsThis study demonstrates that the risk of developing a second IMID is significantly higher for individuals who have already experienced a first IMID in a large and contemporary US claims database. Certain pairs of IMIDs co-occur more frequently than others. The risk of developing subsequent IMIDs may be an important consideration for clinicians when selecting treatment strategies.FundingAbbvie.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Celiac Disease | Coeliac Disease | Databases & Libraries | Drugs & Pharmacology | Environmental Health | Genetics | Health Insurance | Hidradenitis | Inflammatory Bowel Disease | Insurance | Lupus | Psoriasis | Psoriatic Arthritis | Rheumatology | Study